Screening for toxoplasmosis in pregnancy

Lancet

Volumn 369, Issue 9564, 2007, Pages 823-824

  Martinelli, Pasquale ^a   Agangi, Annalisa ^a   Maruotti, Giuseppe M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ANXIETY; COST; FALSE POSITIVE RESULT; HUMAN; IMMUNOASSAY; ITALY; LETTER; MASS SCREENING; MATERNAL CARE; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL PERIOD; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; TOXOPLASMOSIS;

EID: 33847673171     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60403-6     Document Type: Letter

References (5)

1. The SYROCOT (Systematic Review on Congenital Toxoplasmosis) study group. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 13 (2007) 115-122
2. Gilbert R., Gras L., Wallon M., Peyron F., Ades A., and Dunn D. Effect of prenatal treatment on mother to child transmission of Toxoplasma condii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 30 (2001) 1303-1308
3. Chervenak J., Chervenak F., and McCullough L. Ethical and legal dimensions of medicine of the pregnant woman and fetus. In: Reece E., and Hobbins J. (Eds). Medicine of the fetus and the mother. 2nd edn. (1999), Lippincott Raven, Philadelphia
4. Liesenfeld O., Press G., Montoya J., et al. False-positive results in immunoglobulin M (IgM) Toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35 (1997) 174-178
5. Roberts A., Hedman K., Luyasu V., et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 20 (2001) 467-474